Study Findings from Mount Sinai Medical Center Broaden Understanding of Multiple Myeloma [Health-related Quality of Life In Patients Given Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma (Cartitude-1): a Phase 1b-2, ...]

Press/Media

Period24 Mar 2023

Media coverage

1

Media coverage

  • TitleStudy Findings from Mount Sinai Medical Center Broaden Understanding of Multiple Myeloma [Health-related Quality of Life In Patients Given Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma (Cartitude-1): a Phase 1b-2, ...]
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date24/03/23
    PersonsSundar Jagannath